The funds described herein are open to “accredited investors” only, through an offering made in accordance with Regulation D, Rule 506(c) of the Securities Act of 1933, as amended. In purchasing securities through a 506(c) offering, we are obligated to verify any participating investor’s status as an “accredited investor” in accordance with Rule 501 of Regulation D. Investors should consider the investment objectives, risks, charges, and expenses of the fund carefully before investing. We do not make any representations as to the accuracy or completeness of the information contained on this website and undertake no obligation to update the information. Past performance is not an indicator of any future results. All investments contain risk and may lose value. This does not constitute an offer to sell or a solicitation of interest to purchase any securities or investment advisory services in any country or jurisdiction in which such offer or solicitation is not permitted by law.

How to Sell and Close in the Medical Industry – David Karli

In this Show

David C. Karli, CEO & Founder of his own biotech startup, Greyledge Technologies. He speaks about challenges he faced in the early stages of his brand development. He studied from Grant Cardone’s sales experience to work through the challenges that came up along the way. Greyledge is unique because they provide a service to physicians and hospitals.

The major problem Karli faced was getting people to sign on the dotted line. People were always excited and interested about working with Greyledge, but had a long lag time between initial interest and closing the deal. It was taking too long to launch the account and wait until the account actually generated cashflow.

Get in contact with David C. Karli through his website, LinkedIn, and learn more about Greyledge Technologies here:

davidkarli.com

https://www.linkedin.com/in/davidkarli/

https://www.greyledgebiotech.com/

(Visited 94 times, 1 visits today)